Recombinant CD138 (Indatuximab Biosimilar) antibody

Catalog No. ABIN7597747

The Chimeric Chimeric anti-CD138 (Indatuximab Biosimilar) antibody has been validated for . It is suitable to detect CD138 (Indatuximab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD138 (Indatuximab Biosimilar) antibody (ABIN7597747)

Target: CD138 (Indatuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This CD138 (Indatuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD138 (Indatuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Indatuximab Biosimilar Antibody

Specificity: CD138, SDC1, SDC, Syndecan-1, SYND1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD138 (Indatuximab Biosimilar)

Target: CD138 (Indatuximab Biosimilar)

Alternative Name: Indatuximab Biosimilar

Target Type: Biosimilar

Background: CD138, SDC1, SDC, Syndecan-1, SYND1

UniProt: P18827